Ingestible Sensor to Monitor Gut Health Using Genetically Engineered Bacteria

Novel ingestible sensors are equipped with genetically engineered bacteria, which have applications in diagnosis of stomach bleeding and other gastrointestinal disorders

Researchers from MIT developed novel bacteria on a chip system, which comprise genetically engineered bacteria to detect specific molecules placed in four wells of the custom-designed sensor. It is attached to a microprocessor that converts the sensory information to a wireless signal. The research was published in the journal Science in May 2018. As a part of the study, team genetically engineered a probiotic strain of E. coli, which has ability to respond a chemical compound call heme. Heme is found in red-blood cells and it is used as biomarker for detection of internal bleeding. Engineered bacteria emits specific amount of light upon detection of heme.

Furthermore, transport method was developed for bacterial sensors through a body by instantly translating the signals into data. “Our idea was to package bacterial cells inside a device,” said Phillip Nadeau, one of the lead authors on the study. “The cells would be trapped and go along for the ride as the device passes through the stomach.” The entire device fits in a capsule-shaped cylinder about 1.5 inches (3.8 cm) long. The prototype device was equipped with a 2.7-volt battery, which is estimated to offer 1.5 months use.

However, future iterations could be entirely self-powered, as the same team previously developed a battery-free device that generates electricity from stomach acid. As a result of the study, it was found that, device accurately detected the presence of blood in the stomach of pigs. Furthermore, researchers are working on developing bacterial sensors pointing to other potential future diagnostic uses. Also, they are working on reducing the size of the capsule sensor and examine how long these engineered bacterial cells can survive.

You may be interested

New Study Reveals Link between Toothpaste Ingredient and Colon Cancer
Healthcare
Healthcare

New Study Reveals Link between Toothpaste Ingredient and Colon Cancer

Mohit Joshi - September 22, 2018

Recent study reported that common compound found in soaps and toothpaste called triclosan can potentially increase risk for developing colon inflammation and cancer Study highlighted effect of…

Hormone Replacement Therapy Market – Latest Advancements & Outlook 2018 to 2026, Global Top Players : Novartis, Abbott, Mylan, Merck KgaA, Bayer, Pfizer, Novo Nordisk, QuatRx, Teva Pharma., Amgen, Eli Lilly
Healthcare
Healthcare

Hormone Replacement Therapy Market – Latest Advancements & Outlook 2018 to 2026, Global Top Players : Novartis, Abbott, Mylan, Merck KgaA, Bayer, Pfizer, Novo Nordisk, QuatRx, Teva Pharma., Amgen, Eli Lilly

Alex Mathew - September 22, 2018

According to a new market research study titled Hormone Replacement Therapy Market to 2026 – Global Analysis and Forecasts by Material Composition, Industries and End Products”, The…

Corporate Wellness Market Segmentation Application Technology & Market Analysis Report, Global Top Players : EXOS, Hooper Holmes, Wellness Corporate Solutions, ComPsych, United Health Group, Sodexo, BupaWellness
Healthcare
Healthcare

Corporate Wellness Market Segmentation Application Technology & Market Analysis Report, Global Top Players : EXOS, Hooper Holmes, Wellness Corporate Solutions, ComPsych, United Health Group, Sodexo, BupaWellness

Albert R - September 22, 2018

According to a new market research study titled Corporate Wellness Market to 2026 – Global Analysis and Forecasts by Material Composition, Industries and End Products”, The report…

Most from this category